Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-15
2008-04-15
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S194000
Reexamination Certificate
active
07358267
ABSTRACT:
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by an uncoupling protein. In particular, the compounds of the invention modulate the expression and/or activity of UCP3. The subject compositions are particularly useful in the treatment of obesity and type II diabetes, and associated diseases
REFERENCES:
patent: 5342851 (1994-08-01), Sanfilippo et al.
patent: 5849581 (1998-12-01), Hirose et al.
patent: 6492401 (2002-12-01), Hamanaka et al.
patent: WO 96/05861 (1996-02-01), None
Sanfilippo et al., “Novel Thiazole-Based Heterocycles as Selective Inhibitors of Fibrinogen-Mediated Platelet Aggregation,” J. Med. Chem., vol. 38, pp. 34-41 (1995).
Kapoor et al. Indian Journal of Heterocyclic Chemistry 1997, 7(1), 1-4.
Crowe et al. Breast Cancer Research 2004, 6(5), R546-R555.
Gunter et al. Journal of Nutritional Biochemistry 2006, 17, 145-156.
Harper et al. Current Opinions in Pharmacology 2004, 4, 603-7.
Argyropoulos, George, et al., “Effects of Mutations in the Human uncoupling Protein 3 Gene on the Respiratory Quotient and Fat Oxidation in Severe Obesity and Type 2 Diabetes”, J. Clin. Invest., 102:(7), Oct. 1998, 1345-1351.
Boss, Oliver, et al., “Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue- specific expression”, FEBS Lett., 1997, 408 :39-42.
Boss, Oliver, et al., “Genomic Structuring of Uncoupling Potein-3 (UCP3) and Its Assignment to Chromosome 11q13”, Genomics, 1998, 47:425-426.
Bouchard, Claude, et al., “Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans”, Hum. Molec. Genet., 1997, 6 (11):1887-1889.
Brown Angela, et al., “Endogenous mutations in human uncoupling protein 3 alter its functional properties”, FEBS Lett., 1999 464:189-193.
Clapham, John C., et al., “Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean”, Nature, Jul. 27, 2000, 406:415-418.
Fleury, Christophe, et al., “Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia”, Nature Genetics, Mar. 15, 1997, 15: 269-272.
Gong, Da-Wei, et al., “Lack of obesity and natural response to fasting and thyroid Hormone in Mice lacking Uncoupling Protein-3”, J. Biol. Chem., May 26, 2000, 275:16251-16257.
Gura, Trisgha, “Uncoupling Proteins Provide New Clue to Obesity's Causes”, Science, May 29, 1998, 280: ( Issue 5368) 1369-1370.
Millet, Laurence, et al., “IncreasedUncoupling Protein-2and -3mRNA Expression during Fasting in Obese and Lean Human”, J. Clin. Invest., Dec. 11, 1997, 100 (11): 2665-2670.
Naeger, Lisa K., et al., “Identification of a STAT4 Binding Site in the interleukin-12 Receptor Required for Signaling”, J Biol Chem, Jan. 22, 1999, 274(4): 1875-1878.
Nicholls, D.G., et al., “Thermogenic Mechaisms in Brown Fat”, Physiol. Review, 1984, 64(1):1-64.
Sanfilippo, Pauline J., “Novel Thiazole Based Heterocycles as inhibitors of LFA-1/ICAM-1 Mediated Cell Adhesion”, J. Med. Chem., 1995, 38:1057-1059.
Scarpace, P.J., “UCP2, UCP3 are leptin gene expressin: modulation by food restriction and leptin”, J. of Endocrinol., 1998, 159:349-357.
Surwit, Richard S., “Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice”, Proc. Nat. Acad. Sci. USA, Mar. 1998, 95:4061-4065.
Vidal-Puig, Antonio J., et al., “Energy Metabolism in Uncoupling Protein 3 Gene Knockout Mice”, J. Microbiol. Chem. May 26, 2000, 275 (21):16258-16266.
Vidal-Puig, Antonio J., et al., “UCP3: An uncoupling Protein Homologue Expressed Preferentially and Abundantly in Skeletal Muscle and Brown Adipose Tissue”, Biochem. Biophys. Res. Comm., 1997, 235:79-82.
Walder, Ken, et al., “Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians”, Hum. Molec. Genet., 1998, 7(9):1431-1435.
Amaral M. Catherine
Chen Jin-Long
Jaen Juan C.
Johnston David N.
Rafferty Paul
Amgen Inc.
Nolan Jason M
Saeed Kamal A.
Smith Christopher J.
LandOfFree
Bis-aryl thiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-aryl thiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-aryl thiazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2790123